Literature DB >> 29752412

Properly folded and functional PorB from Neisseria gonorrhoeae inhibits dendritic cell stimulation of CD4+ T cell proliferation.

Weiyan Zhu1, Joshua Tomberg2, Kayla J Knilans2, James E Anderson1, Karen P McKinnon3,4, Gregory D Sempowski5, Robert A Nicholas6,3, Joseph A Duncan7,2,4.   

Abstract

Neisseria gonorrhoeae is an exclusive human pathogen that evades the host immune system through multiple mechanisms. We have shown that N. gonorrhoeae suppresses the capacity of antigen-presenting cells to induce CD4+ T cell proliferation. In this study, we sought to determine the gonococcal factors involved in this adaptive immune suppression. We show that suppression of the capacity of antigen-pulsed dendritic cells to induce T cell proliferation is recapitulated by administration of a high-molecular-weight fraction of conditioned medium from N. gonorrhoeae cultures, which includes outer membrane vesicles that are shed during growth of the bacteria. N. gonorrhoeae PorB is the most abundant protein in N. gonorrhoeae-derived vesicles, and treatment of dendritic cells with purified recombinant PorB inhibited the capacity of the cells to stimulate T cell proliferation. This immunosuppressive feature of purified PorB depended on proper folding of the protein. PorB from N. gonorrhoeae, as well as other Neisseria species and other Gram-negative bacterial species, are known to activate host Toll-like receptor 2 (TLR2) signaling. Published studies have demonstrated that purified Neisseria PorB forms proteinacious nanoparticles, termed proteosomes, when detergent micelles are removed. Unlike folded, detergent-solubilized PorB, PorB proteosomes stimulate immune responses. We now demonstrate that the formation of PorB proteosomes from structurally intact PorB eliminates the immunosuppressive property of the protein while enhancing TLR2 stimulation. These findings suggest that gonococcal PorB present in shed outer membrane vesicles plays a role in suppression of adaptive immune responses to this immune-evasive pathogen.
© 2018 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Neisseria gonorrhoeae; T cell; Toll-like receptor (TLR); Toll-like receptor 2 (TLR2); dendritic cell; immunosuppression; outer membrane; outer membrane vesicle; porin

Mesh:

Substances:

Year:  2018        PMID: 29752412      PMCID: PMC6052219          DOI: 10.1074/jbc.RA117.001209

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  49 in total

1.  Opposing selective forces for expression of the gonococcal lactoferrin receptor.

Authors:  James E Anderson; Marcia M Hobbs; Gour D Biswas; P Frederick Sparling
Journal:  Mol Microbiol       Date:  2003-06       Impact factor: 3.501

2.  Porin-mediated antibiotic resistance in Neisseria gonorrhoeae: ion, solute, and antibiotic permeation through PIB proteins with penB mutations.

Authors:  Melanie Olesky; Shuqing Zhao; Robert L Rosenberg; Robert A Nicholas
Journal:  J Bacteriol       Date:  2006-04       Impact factor: 3.490

Review 3.  Emergence of multidrug-resistant, extensively drug-resistant and untreatable gonorrhea.

Authors:  Magnus Unemo; Robert A Nicholas
Journal:  Future Microbiol       Date:  2012-12       Impact factor: 3.165

Review 4.  Antimicrobial resistance in Neisseria gonorrhoeae.

Authors:  K K Fox; J S Knapp
Journal:  Curr Opin Urol       Date:  1999-01       Impact factor: 2.309

5.  Neisserial porin-induced dendritic cell activation is MyD88 and TLR2 dependent.

Authors:  Theresa E Singleton; Paola Massari; Lee M Wetzler
Journal:  J Immunol       Date:  2005-03-15       Impact factor: 5.422

6.  Neutral sphingomyelinase 2 is a key factor for PorB-dependent invasion of Neisseria gonorrhoeae.

Authors:  Michaela Faulstich; Franziska Hagen; Elita Avota; Vera Kozjak-Pavlovic; Ann-Cathrin Winkler; Yibo Xian; Sibylle Schneider-Schaulies; Thomas Rudel
Journal:  Cell Microbiol       Date:  2014-10-31       Impact factor: 3.715

7.  Toll-Like Receptor Ligand-Based Vaccine Adjuvants Require Intact MyD88 Signaling in Antigen-Presenting Cells for Germinal Center Formation and Antibody Production.

Authors:  Munir M Mosaheb; Michael L Reiser; Lee M Wetzler
Journal:  Front Immunol       Date:  2017-03-03       Impact factor: 7.561

8.  Control of gdhR Expression in Neisseria gonorrhoeae via Autoregulation and a Master Repressor (MtrR) of a Drug Efflux Pump Operon.

Authors:  Corinne E Rouquette-Loughlin; Yaramah M Zalucki; Vijaya L Dhulipala; Jacqueline T Balthazar; Raúl G Doyle; Robert A Nicholas; Afrin A Begum; Erica L Raterman; Ann E Jerse; William M Shafer
Journal:  mBio       Date:  2017-04-11       Impact factor: 7.867

9.  Bacterial porin disrupts mitochondrial membrane potential and sensitizes host cells to apoptosis.

Authors:  Vera Kozjak-Pavlovic; Elke A Dian-Lothrop; Michael Meinecke; Oliver Kepp; Katharina Ross; Krishnaraj Rajalingam; Anke Harsman; Eva Hauf; Volker Brinkmann; Dirk Günther; Ines Herrmann; Robert Hurwitz; Joachim Rassow; Richard Wagner; Thomas Rudel
Journal:  PLoS Pathog       Date:  2009-10-23       Impact factor: 6.823

10.  In vivo and in vitro characterization of the immune stimulating activity of the Neisserial porin PorB.

Authors:  Andrew Platt; Heather MacLeod; Paola Massari; Xiuping Liu; Lee Wetzler
Journal:  PLoS One       Date:  2013-12-11       Impact factor: 3.240

View more
  6 in total

1.  Meningococcal Detoxified Outer Membrane Vesicle Vaccines Enhance Gonococcal Clearance in a Murine Infection Model.

Authors:  Kathryn A Matthias; Kristie L Connolly; Afrin A Begum; Ann E Jerse; Andrew N Macintyre; Gregory D Sempowski; Margaret C Bash
Journal:  J Infect Dis       Date:  2022-02-15       Impact factor: 7.759

2.  Immune Responses to Neisseria gonorrhoeae: Challenges and Opportunities With Respect to Pelvic Inflammatory Disease.

Authors:  Michael W Russell
Journal:  J Infect Dis       Date:  2021-08-16       Impact factor: 7.759

3.  Quantitative Proteomics of the 2016 WHO Neisseria gonorrhoeae Reference Strains Surveys Vaccine Candidates and Antimicrobial Resistance Determinants.

Authors:  Fadi E El-Rami; Ryszard A Zielke; Teodora Wi; Aleksandra E Sikora; Magnus Unemo
Journal:  Mol Cell Proteomics       Date:  2018-10-23       Impact factor: 5.911

Review 4.  Pathogenesis of Neisseria gonorrhoeae and the Host Defense in Ascending Infections of Human Fallopian Tube.

Authors:  Jonathan D Lenz; Joseph P Dillard
Journal:  Front Immunol       Date:  2018-11-21       Impact factor: 7.561

Review 5.  Progress Toward a Gonococcal Vaccine: The Way Forward.

Authors:  Michael W Russell; Ann E Jerse; Scott D Gray-Owen
Journal:  Front Immunol       Date:  2019-10-15       Impact factor: 7.561

6.  The serogroup B meningococcal outer membrane vesicle-based vaccine 4CMenB induces cross-species protection against Neisseria gonorrhoeae.

Authors:  Isabelle Leduc; Kristie L Connolly; Afrin Begum; Knashka Underwood; Stephen Darnell; William M Shafer; Jacqueline T Balthazar; Andrew N Macintyre; Gregory D Sempowski; Joseph A Duncan; Marguerite B Little; Nazia Rahman; Eric C Garges; Ann E Jerse
Journal:  PLoS Pathog       Date:  2020-12-08       Impact factor: 6.823

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.